These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 11326687

  • 1. Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
    Mazurek S, Grimm H, Oehmke M, Weisse G, Teigelkamp S, Eigenbrodt E.
    Anticancer Res; 2000; 20(6D):5151-4. PubMed ID: 11326687
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The tumor metabolome.
    Mazurek S, Eigenbrodt E.
    Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
    Mazurek S.
    Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
    [Abstract] [Full Text] [Related]

  • 6. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
    Koss K, Harrison RF, Gregory J, Darnton SJ, Anderson MR, Jankowski JA.
    J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R.
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
    Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA.
    Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
    [Abstract] [Full Text] [Related]

  • 14. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.
    Matusiak D, Glover S, Nathaniel R, Matkowskyj K, Yang J, Benya RV.
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G718-28. PubMed ID: 15528253
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets.
    Marimuthu S, Chivukula RS, Alfonso LF, Moridani M, Hagen FK, Bhat GJ.
    Int J Oncol; 2011 Nov; 39(5):1273-83. PubMed ID: 21743961
    [Abstract] [Full Text] [Related]

  • 17. Enzyme activities in normal, dysplastic, and cancerous human breast tissues.
    Balinsky D, Platz CE, Lewis JW.
    J Natl Cancer Inst; 1984 Feb; 72(2):217-24. PubMed ID: 6582310
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
    Sanfilippo O, Camici M, Tozzi MG, Turriani M, Faranda A, Ipata PL, Silvestrini R.
    Cancer Biochem Biophys; 1994 Apr; 14(1):57-66. PubMed ID: 7796389
    [Abstract] [Full Text] [Related]

  • 19. Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.
    Schneider J, Neu K, Grimm H, Velcovsky HG, Weisse G, Eigenbrodt E.
    Anticancer Res; 2002 Apr; 22(1A):311-8. PubMed ID: 12017309
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.